An in vitro study on the influence of limited frequency resolution on contrast agent-enhanced Doppler signals

Ultrasound contrast agents for vascular use are gas-filled microspheres and will increase the backscatter from blood and therefore enhance the Doppler signal. Studies have shown that Doppler enhancement may result in an increased maximum velocity when observed as the envelope of the spectral Doppler screen. Change in observed velocity may be due to biological or instrumentational effects. The purpose of this study was to investigate the possible instrumentational effects on the Doppler signal after injection of the contrast agent (Infoson ™). By performing the measurements on a Doppler phantom, the biological effects was eliminated. Computer simulations of limited frequency resolution were compared to measurements. The conclusion was that the increase in detected maximum velocity after Infoson injection is due to the combined effect of signal enhancement and limited frequency resolution. It is shown that a large change in signal strength can change the estimated maximum frequency from the spectral Doppler whether this is due to a contrast agent or instrument settings. It is therefore important in a clinical situation to have an adequate, but not too strong or too weak signal in order to make the best velocity estimates.